Suitability of the ICH S1B(R1) Weight-of-Evidence Framework to Evaluate Glucagon-Like Protein-1 Receptor Agonist (GLP-1RA) Carcinogenicity Risk
- DOI
- 10.1016/j.yrtph.2026.106252
- Published
- 2026-09
- Container
- Regulatory Toxicology and Pharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.yrtph.2026.106252,
title = {Suitability of the ICH S1B(R1) Weight-of-Evidence Framework to Evaluate Glucagon-Like Protein-1 Receptor Agonist (GLP-1RA) Carcinogenicity Risk},
author = {Katherine A. Roach and Manoochehr Khazaee and Isaac Mohar and Denali Boon and Brigitte Cronin and Alex G. Gauthier},
year = {2026},
journal = {Regulatory Toxicology and Pharmacology},
doi = {10.1016/j.yrtph.2026.106252},
url = {https://doi.org/10.1016/j.yrtph.2026.106252}
}RIS
TY - JOUR TI - Suitability of the ICH S1B(R1) Weight-of-Evidence Framework to Evaluate Glucagon-Like Protein-1 Receptor Agonist (GLP-1RA) Carcinogenicity Risk AU - Katherine A. Roach AU - Manoochehr Khazaee AU - Isaac Mohar AU - Denali Boon AU - Brigitte Cronin AU - Alex G. Gauthier PY - 2026 JO - Regulatory Toxicology and Pharmacology DO - 10.1016/j.yrtph.2026.106252 UR - https://doi.org/10.1016/j.yrtph.2026.106252 ER -
APA
Roach, K. A., Khazaee, M., Mohar, I., Boon, D., Cronin, B., & Gauthier, A. G. (2026). Suitability of the ICH S1B(R1) Weight-of-Evidence Framework to Evaluate Glucagon-Like Protein-1 Receptor Agonist (GLP-1RA) Carcinogenicity Risk. Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2026.106252
Source records
- crossref · retrieved 2026-09-27T12:25:24.391Z